Axsome Therapeutics, Inc

AXSM XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

12B

Short interest (Jul 15)

5.9%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.33%

↑ 9.3%

Available Shares

↑ 14.6%

Price Chart

Company Overview

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001579428

Asset Type: CS

Market Data

Market Cap: $12,401,803,606

Employees: 925

Status: Active

Short Interest

Current Borrow Fee 0.33%

Range: 0.33% - 0.33%

Available Shares 1M

Range: 850K - 1.2M

Recent Changes

Fee Change: ↑ 20.0%

Available Change: ↓ 4.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime